| Heart disease and stroke statistics—2014 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ... circulation 129 (3), e28-e292, 2014 | 15921 | 2014 |
| 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and … B Williams, G Mancia, W Spiering, E Agabiti Rosei, M Azizi, M Burnier, ... European heart journal 39 (33), 3021-3104, 2018 | 11702 | 2018 |
| 2016 European Guidelines on cardiovascular disease prevention in clinical practice MF Piepoli, AW Hoes, S Agewall, C Albus, C Brotons, AL Catapano, ... Kardiologia Polska (Polish Heart Journal) 74 (9), 821-936, 2016 | 9487 | 2016 |
| 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD F Cosentino, L David European heart journal 41 (2), 255-323, 2020 | 6001* | 2020 |
| Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies Emerging Risk Factors Collaboration The lancet 375 (9733), 2215-2222, 2010 | 5102 | 2010 |
| Genetic studies of body mass index yield new insights for obesity biology AE Locke, B Kahali, SI Berndt, AE Justice, TH Pers, FR Day, C Powell, ... Nature 518 (7538), 197-206, 2015 | 4184 | 2015 |
| Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials N Sattar, D Preiss, HM Murray, P Welsh, BM Buckley, AJM de Craen, ... The Lancet 375 (9716), 735-742, 2010 | 3025 | 2010 |
| Major lipids, apolipoproteins, and risk of vascular disease R Assessment Jama 302 (18), 1993-2000, 2009 | 2845 | 2009 |
| Cardiovascular and renal outcomes with empagliflozin in heart failure M Packer, SD Anker, J Butler, G Filippatos, SJ Pocock, P Carson, ... New England Journal of Medicine 383 (15), 1413-1424, 2020 | 2786 | 2020 |
| C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis Emerging Risk Factors Collaboration The Lancet 375 (9709), 132-140, 2010 | 2579 | 2010 |
| Diabetes mellitus, fasting glucose, and risk of cause-specific death Emerging Risk Factors Collaboration New England Journal of Medicine 364 (9), 829-841, 2011 | 2527 | 2011 |
| Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents E Di Angelantonio, SN Bhupathiraju, D Wormser, P Gao, S Kaptoge, ... The Lancet 388 (10046), 776-786, 2016 | 2259 | 2016 |
| 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with … FLJ Visseren, F Mach, YM Smulders, D Carballo, KC Koskinas, M Bäck, ... European heart journal 42 (34), 3227-3337, 2021 | 2110 | 2021 |
| EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis MJL Peters, DPM Symmons, D McCarey, BAC Dijkmans, P Nicola, ... Annals of the rheumatic diseases 69 (2), 325-331, 2010 | 2097 | 2010 |
| Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study N Sattar, A Gaw, O Scherbakova, I Ford, DSJ O’Reilly, SM Haffner, C Isles, ... Circulation 108 (4), 414-419, 2003 | 2067 | 2003 |
| Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials KK Ray, SRK Seshasai, S Wijesuriya, R Sivakumaran, S Nethercott, ... The Lancet 373 (9677), 1765-1772, 2009 | 1772 | 2009 |
| Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis D Preiss, SRK Seshasai, P Welsh, SA Murphy, JE Ho, DD Waters, ... Jama 305 (24), 2556-2564, 2011 | 1770 | 2011 |
| Empagliflozin in heart failure with a preserved ejection fraction SD Anker, J Butler, G Filippatos, JP Ferreira, E Bocchi, M Böhm, ... New England Journal of Medicine 385 (16), 1451-1461, 2021 | 1749 | 2021 |
| Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial MEJ Lean, WS Leslie, AC Barnes, N Brosnahan, G Thom, L McCombie, ... The Lancet 391 (10120), 541-551, 2018 | 1512 | 2018 |
| Explaining how “high-grade” systemic inflammation accelerates vascular risk in rheumatoid arthritis N Sattar, DW McCarey, H Capell, IB McInnes Circulation 108 (24), 2957-2963, 2003 | 1349 | 2003 |
David PreissAssociate Professor, University of OxfordVerified email at ndph.ox.ac.uk
